{
    "Trade/Device Name(s)": [
        "Quidel Molecular Influenza A + B Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K112172",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092500"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "001"
    ],
    "Summary Letter Date": "December 22, 2011",
    "Summary Letter Received Date": "November 30, 2011",
    "Submission Date": "November 29, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NucliSENS easyMAG",
        "Applied Biosystems 7500 Fast Dx"
    ],
    "Method(s)/Technology(ies)": [
        "Real Time RT-PCR",
        "Multiplex PCR",
        "TaqMan chemistry"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid amplification and detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Extraction kit"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel Molecular Influenza A + B multiplex RT-PCR assay for detection and differentiation of influenza A and B viral RNA in nasal and nasopharyngeal swabs.",
    "Indications for Use Summary": "Multiplex RT-PCR assay for qualitative detection and differentiation of influenza A and B viral RNA in nasal and nasopharyngeal swabs from symptomatic patients, aiding differential diagnosis of influenza A and B infection in conjunction with clinical and epidemiological factors.",
    "fda_folder": "Microbiology"
}